13F manager/TSHA/

Jefferies Group trim Taysha Gene Therapies, Inc.

Jefferies Group trim $7.1M of disclosed value in Taysha Gene Therapies, Inc..

Signal
Investor Move
Action
Trim
Capital
$7.1M disclosed value

Why it matters

This action comes from parsed SEC 13F holdings and highlights where tracked institutional capital changed materially versus the previous comparable filing period.

Evidence